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Factors predicting malnutrition in hemodialysis patients: A cross-
sectional study. Signs of protein-energy malnutrition are common in
maintenance hemodialyis (HD) patients and are associated with increased
morbidity and mortality. To evaluate the nutritional status and relation-
ship between various parameters used for assessing malnutrition, we
performed a cross-sectional study in 128 unselected patients treated with
hemodialysis (HD) thrice weekly for at least two weeks. Global nutritional
status was evaluated by the subjective global nutritional assessment
(SGNA). Body weight, skinfold thicknesses converted into % body fat
mass (BFM), mid-arm muscle circumference, hand-grip strength and
several laboratory values, including serum albumin (SAlb), plasma insulin-
like growth factor I (p-IGF-I), serum C-reactive protein (SCRP) and
plasma free amino acids, were recorded. Dose of dialysis and protein
equivalence of nitrogen appearance (nPNA) were evaluated by urea
kinetic modeling. The patients were subdivided into three groups based on
SGNA: group I, normal nutritional status (36%); group II, mild malnu-
trition (51%); and group III, moderate or (in 2 cases) severe malnutrition
(13%). Clinical factors associated with malnutrition were: high age,
presence of cardiovascular disease and diabetes mellitus. nPNA and
Kt/Vurea were similar in the three groups. However, when normalized to
desirable body wt, both were lower in groups II and III than in group I.
Anthropometric factors associated with malnutrition were low body wt,
skinfold thickness, mid-arm muscle circumference (MAMC), and hand-
grip strength. Biochemical factors associated with malnutrition were low
serum levels of albumin and creatinine and low plasma levels of insulin-
like growth factor 1 (IGF-1) and branched-chain amino acids (isoleucine,
leucine and valine). The serum albumin (SAlb) level was not only a
predictor of nutritional status, but was independently influenced by age,
sex and SCRP. Plasma IGF-1 levels also reflected the presence and severity
of malnutrition and appeared to be more closely associated than SAlb with
anthropometric and biochemical indices of somatic protein mass. Elevated
SCRP (. 20 mg/liter), which mainly reflected the presence of infection/
inflammation and was associated with hypoalbuminemia, was more com-
mon in malnourished patients than in patients with normal nutritional
status, and also more common in elderly than in younger patients. Plasma
amino acid levels, with the possible exception of the branched-chain amino
acids (isoleucine, leucine, valine), seem to be poor predictors of nutri-
tional status in hemodialysis patients.
Protein-energy malnutrition and wasting are present in a large
proportion of patients with chronic renal failure. This may be a
consequence of multiple factors, including disturbances in protein
and energy metabolism, hormonal derangements, infections and
other superimposed illnesses, as well as reduced food intake
because of anorexia, nausea and vomiting, caused by uremic
toxicity. After commencement of maintenance dialysis treatment,
most of the overt symptoms of uremia diminish or disappear and
the patients generally experience increased well-being and im-
proved appetite. However, several reports show that the preva-
lence of protein-energy malnutrition in dialysis patients is high. In
hemodialysis (HD) patients between 23 to 76% are reported to be
malnourished, the variability presumably being related to factors
such as age, case mix, co-morbid conditions and quality of dialysis
therapy [1–7].
During recent years, several studies in HD patients have shown
an association between signs of malnutrition, particularly low
serum albumin, and increased morbidity and mortality [8–11].
However, the extent to which this reflects a cause-effect relation-
ship is not clear, since several co-morbidity factors, which are of
more importance as causes of death per se, may have secondary
effects on various parameters used to assess the nutritional status
[12].
The present cross-sectional study of nutritional status was
performed to assess the prevalence and degree of protein-energy
malnutrition in a population of HD patients in Stockholm,
Sweden. Another aim was to evaluate the relationship between
various parameters used to evaluate the nutritional status and to
analyze how co-morbid factors influenced these parameters.
Among the biochemical measurements, we included serum C-re-
active protein, considering that this acute phase protein is a
marker of co-morbidity and that the acute phase response inhibits
the generation of serum albumin [13, 14], which is generally used
as a nutritional marker in patients with renal failure.
METHODS
Patients
All patients with chronic renal failure who were treated with
maintenance HD at the various dialysis centers affiliated with the
Renal Clinic, Huddinge University Hospital and who had been on
hemodialysis for at least two weeks were eligible for inclusion in
the present study. Of a total of 164 patients, 128 (76 males and 52
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females, median age 65 years range 26 to 84 years) agreed to
participate, while 36 either refused or the staff did not cooperate.
The causes of renal failure in the 128 patients were diabetic
nephropathy (N 5 23), chronic glomerulonephritis (N 5 38),
polycystic kidney disease (N 5 13), pyelonephritis and interstitial
nephritis (N 5 14), and other diseases or unknown etiology (N 5
40). Thirteen of the diabetic patients were insulin-dependent.
Seventy-seven patients had signs of cardiovascular and/or periph-
eral vascular disease (grouped as CVD). Of these, 20 had suffered
one or more myocardial infarctions, 15 had ischemic heart disease
but no prior myocardial infarction, one had an aortic aneurysm
and 11 had peripheral ischemic atherosclerotic vascular disease.
Nineteen patients suffered from chronic heart failure. Six patients
had cerebrovascular disease with neurological symptoms, follow-
ing one or more attacks of stroke; all these patients also had signs
of cardiovascular disease. Of the 23 diabetic patients, 17 had
CVD. Three patients had increased serum aspartate aminotrans-
ferase levels at the time of the study. Ninety-six patients had no
residual renal function, defined as renal urea clearance , 0.5
ml/min.
The patients were treated with oral sodium bicarbonate, cal-
cium carbonate and/or aluminum hydroxide, as required to pre-
vent acidosis and hyperphosphatemia. Forty patients were taking
anti-hypertensive drugs such as angiotensin-converting enzyme
inhibitors, beta-blockers and calcium-blockers. Fifteen patients
with residual renal function were treated with high doses of
furosemide (250 to 500 mg/day) to increase urinary output and
renal sodium excretion. Recombinant human erythropoietin was
given to 74 patients. All patients were prescribed water soluble
vitamins (B and C) as multivitamin tablets. Fourteen patients
were hospitalized at the time of the investigation.
Hemodialysis (HD) was performed three times per week.
Dialyzers with low-permeability, modified cellulosic membranes
(cellular acetate or hemophan) were used in 120 patients; mem-
brane surface areas were 1.0 m2 (N 5 1), 1.3 m2 (N 5 7), 1.7 m2
(N 5 81), 1.8 m2 (N 5 27) and 2.1 m2 (N 5 4). Eight patients were
treated with high-flux polysulfone dialyzers having membrane
areas of 1.3 m2 (N 5 1) and 1.9 m2 (N 5 7). The dialyzers were
not reused. The protein equivalent of nitrogen appearance
(PNA), which in steady state patients gives an approximation of
the protein intake [15], was estimated from the determination of
the urea appearance rate by urea kinetic modelling, using the
single pool, variable volume model, according to Farell and Gotch
[16]. The contribution of residual renal function (renal urea
clearance $ 0.5 ml/min) was included in the calculations. Protein
equivalence of nitrogen equivalence (PNA) per kg absolute body
wt (ABW) was recalculated per “normalized” body wt (nBW),
obtained by dividing the post-dialysis distribution volume of urea
(V) by 0.58 [17]. Thus, nPNA 5 PNA * 0.58/V. Prescribed
Kt/Vurea for one single dialysis was calculated from dialyzer 1
renal urea clearance (K), dialysis time (t) and V obtained by urea
kinetic modelling [16]. Outcome Kt/Vurea was calculated by the
Daugirdas method [18], based on the reduction in the serum urea
concentration during dialysis and taking the effect of ultrafiltra-
tion into consideration. The results with the two methods were
similar; we therefore prefer to present in the results only outcome
Kt/Vurea, since its calculations is independent of technical arti-
facts. The contribution of renal urea clearance was added to K in
the patients who had residual renal function (renal urea clear-
ance $ 0.5 ml/min). Kt/Vurea and PNA were also related to the
desirable body wt (DBW), by calculations based on the patient’s
height, sex and frame size match, using the Metropolitan height
and weight tables [15, 19].
Forty-four healthy volunteers (24 male and 20 females, median
age 34 years range 21 to 64 years) were selected for comparative
analysis of nutritional status, anthropometric and biochemical
variables.
The study protocol was approved by the Ethics Committee of
Karolinska Institute at Huddinge University Hospital, Stockholm,
and informed consent was obtained from each patient and control
subject.
Nutritional status, anthropometric measurements (except abso-
lute) and blood sampling for biochemical analyses were per-
formed in all subjects after an overnight fast; the HD patients
were investigated on a mid-week, dialysis-free day.
Subjective global nutritional assessment
Subjective global nutritional assessment (SGNA) was used to
evaluate the overall protein-energy nutritional status [20, 21]. The
SGNA includes six subjective assessments, three based on the
patient’s history of weight loss, incidence of anorexia and inci-
dence of vomiting, and three based on the physician’s grading of
muscle wasting, presence of edema and loss of subcutaneous fat.
Based on these assessments each patient was given a score that
reflected the nutrtional status as follows: 1 5 normal nutritional
status, 2 5 mild malnutrition, 3 5 moderate malnutrition, and 4 5
severe malnutrition.
Anthropometric measurements
Absolute body wt (ABW) was recorded post-dialysis with the
subjects lightly dressed and without shoes; the patients were also
weighed pre-dialysis. A difference in ABW from normal was
recorded as the percentage of actual to desirable body wt (%A/
DBW). Skinfold thickness was measured with a Harpenden
caliper at four sites (triceps, biceps, subscapular and suprailiac) on
the non-dominant arm of the controls and in the fistula-free arm
of the uremic patients. The results were converted into density, by
the method of Durnin and Womersley [22] and converted into
body fat mass (BFM) by using the equation of Siri [23]. The
mid-arm muscle circumference (MAMC) was derived from the
triceps skinfold thickness (TSF) and mid-arm circumference
(MAC) as follows: MAMC 5 MAC 2 (p * TSF). Hand-grip
strength (HGS) was measured using the Harpenden dynamome-
ter. The subjects were instructed to apply as much hand-grip
pressure as possible, using the dominant hand and the non-
dominant hand. The measurements were repeated three times
and the highest score was recorded. The individual values for
anthropometric variables (BFM, MAMC, HGS) were normalized
by converting them to % of controls, when included in the
correlation and regression analyses. Subjective global nutritional
assessment and the anthropometric measurements were made by
an investigator (A.R.Q.) experienced with these methods. The
investigator was not aware of the biochemical data at the time of
the examination.
Biochemical analyses
Venous blood samples from HD patients and control subjects
were collected immediately before the anthropometric measure-
ments were performed. Blood was also drawn before and after the
first dialysis of the week, and again before the next dialysis for
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urea determinations used to calculate urea kinetics. Blood hemo-
globin, total lymphocyte counts and blood glucose and serum
biochemistries were analyzed by routine methods. Serum albumin
was determined by the bromcresol purple method; this method
underestimates albumin by about 1 g/liter compared to a refer-
ence method using immunonephelometry [24]. Serum C-reactive
protein (SCRP) was measured by using an immunonephelometric
method (Tina-quant®; Boehringer-Mannheim/Hitachi). The up-
per limit for normal values was set by the laboratory at 10 mg/liter
and levels below this limit were reported as normal but not
quantified. Plasma insulin-like growth factor-1 (p-IGF-1) was
measured following acid ethanol extraction using a commercial
radioimmunoassay kit (Nichols Institute, San Juan Capistrano,
CA, USA). For determination of free amino acids, heparinized
blood samples were centrifuged at 3000 g for 15 minutes, plasma
was deproteinized with 5-sulfosalicylic acid (final concentration
3%), and after centrifugation for another 15 minutes the super-
natant was pipetted and stored at 270°C, pending analysis. The
determination of free amino acids in plasma was carried out by
reversed-phase, high-performance liquid chromatography
(HPLC), as described earlier [25].
Statistical analyses
Data are presented as mean 6 SD. A P value , 0.05 was
considered to be significant. Differences between the four groups
were assessed by analysis of variance (ANOVA). When the
ANOVA test was significant, a Dunnett’s test was used to
compare the differences between the control and patient groups.
Differences between the three patient groups were analyzed by
ANOVA, followed by Dunn’s test with Bonferroni correction for
multiple comparisons between the groups. Linear trend across the
groups ordered by severity of malnutrition (groups I, II and III)
was tested by analysis of variance, as described by Altman [26].
Comparisons between two groups for continuous variables were
made by the Student’s t-test or with the Mann-Whitney test for
variables which were not normally distributed and for nominal
variables by the chi-squared test. Spearman’s rank correlation
were used to determine the correlation between 2 variables.
Stepwise multiple regression analysis was used to assess the
influence of multiple variables on a single variable (serum albu-
min, SAlb), entering those variables that correlated significantly
with the single variable by univariate analysis [26]. Stepwise
logistic regression was used to analyze factors that independently
predicted malnutrition, evaluated from SGNA.
RESULTS
Subjective global nutritional assessment
The patients were divided into three groups based on SGNA
(Table 1). Forty-six patients (36%) had a normal nutritional status
(group I), 65 patients (51%) were mildly malnourished (group II)
and 17 patients (13%) were moderately (N 5 15) or severely (N 5
2) malourished and were grouped together (group III).
Clinical data
The median age was higher in groups II and III (68 and 64
years, respectively) than in group I (57 years). The proportion of
female patients was higher in group III (65%) than in groups I and
II (35% and 38%, respectively). The distribution of renal diseases
were similar in the three groups, except for a higher percentage of
diabetic patients in group III (41%) than in groups I and II (11%
and 17%), respectively. The percentages of patients with residual
renal function were 26% in groups I and II and 18% in group III.
The prevalence of CVD was higher in group III (76%) than in
group II (65%) and group I (48%). The mean blood pressure
[diastolic pressure 1 (systolic 2 diastolic pressure)/3] was similar
in the three groups.
Dialysis data
The median length of time on HD treatment was longer in
group I (28 months) than in groups II and III (18 and 13 months,
respectively). The dialysis time tended to be lower in groups II
and III than in group I but the difference was not significant. The
mean nPNA was 1.14, 1.08 and 1.10 g/kg and the mean Kt/Vurea
was 1.34, 1.36 and 1.37 in groups I, II and III, respectively; the
differences were not significant. When normalized to desirable
body wt (DBW), the mean PNA was 1.27, 1.19 and 0.84 in groups
I, II and III, respectively, being significantly lower in groups II and
III than in group I (Fig. 1). The mean Kt/Vurea normalized to
DBW was 1.45, 1.19 and 1.13 in groups I, II and II, respectively,
being significantly lower in groups II and III than in group I.
Anthropometric data
Absolute body weight (ABW), %A/DBW, TSF, BFM and
MAMC in group I were about same as in the controls (Table 2).
The values tended to be lower in group II and were significantly
reduced in group III, as compared to the controls and to group I.
Hand-grip strength (HGS) was significantly lower in all three
Table 1. Clinical and dialysis data in 128 hemodialysis (HD) patients
(mean 6 SD)
Group I Group II Group III
Number of subjects 46 (36%) 65 (51%) 17 (13%)
Age, years (median and range) 57 (26–79) 68 (32–85) 64 (33–83)
Sex, male/female 30/16 40/25 6/11
Patients with residual renal
function, percent
12 (26%) 17 (26%) 3 (18%)
Glomerulonephritis 17 (37%) 20 (31%) 1 (6%)
Polycystic kidney disease 6 (13%) 5 (8%) 2 (12%)
Unknown etiology 9 (20%) 15 (23%) 6 (35%)
Diabetes mellitus 5 (11%) 11 (17%) 7 (41%)a
Pyelonephritis/interstitial
nephritis
5 (11%) 9 (13%) 0 (0%)
Other disease 4 (8%) 5 (8%) 1 (6%)
Prevalence of cardiovascular
disease
22 (48%) 42 (65%) 13 (76%)a
Mean blood pressure, mm Hg 99 6 19 99 6 17 98 6 22
Dialysis data
Months on HD (median
and range)
28 (0.4–316) 18 (0.4–216) 13 (0.4–110)
Interdialytic weight gain, kg 2.33 6 0.85 2.80 6 0.89 2.03 6 1.36
Length of dialysis, hours 4.22 6 0.57 3.74 6 0.39 3.78 6 0.65
Predialysis serum urea,
mmol/liter
27 6 5 27 6 7 26 6 7
Postdialysis serum urea,
mmol/liter
9 6 3 9 6 3 8 6 3
nPNA, g/kg body wt/day 1.14 6 0.27 1.08 6 0.23 1.10 6 0.23
PNA, g/kg desirable body
weight/day
1.23 6 0.27 1.00 6 0.26a 0.88 6 0.16a
Kt/Vurea 1.34 6 0.21 1.36 6 0.26 1.37 6 0.22
Kt/Vurea (corrected to desirable
body weight)
1.45 6 0.34 1.19 6 0.24a 1.13 6 0.18a
a P , 0.05 compared with group I
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patient groups than in the controls. However, when we compared
HGS in group I patients (N 5 21) with age- and sex-matched
controls, there was no significant difference [Controls, females
(N 5 9) 29 6 12, males (N 5 12) 43 6 8. Group I patients, females
(N 5 9) 25 6 5, males (N 5 12) 38 6 10 kg]. Comparing the three
patient groups, there was a significant (P , 0.001) linear trend
towards progressively lower values for %A/DBW, TSF, MAMC,
HGS and BFM with the degree of malnutrition.
Laboratory data
The levels of serum creatinine was significantly lower in group
III than in groups I and II, which presumably reflects a reduced
muscle mass in the moderately to severely malnourished patients
(Table 3). The levels of serum triglycerides, cholesterol, phos-
phate, transferrin and total protein, plasma complement C3,
blood standard bicarbonate, hemoglobin and lymphocyte count
were similar in the three groups of patients.
The SAlb concentration was significantly reduced in all three
patient groups as compared to the controls. Considering that SAlb
in healthy subjects tends to fall with advancing age [27] and that
the control group was younger than the patient groups, we
compared the serum albumin concentration in 27 patients of
group I with the concentration in 27 age-matched controls. The
concentration in these patients was 35 6 5 g/liter and in the
matched controls 41 6 4 g/liter; the difference is highly significant
(P , 0.0001). In a comparison to group I, the SAlb concentration
was lower in group II and even more reduced in group III, with a
significant linear trend (P 5 0.001).
The p-IGF-1 concentration were skewly distributed in each
group. The levels IGF-1 were within the normal range in most
patients in group I, they were lower in group II, and even lower in
group III, with a significant linear trend (P , 0.001).
Serum C-reactive protein (SCRP) was normal (, 10 mg/liter) in
60 patients and elevated in 68 patients, ranging up to 120 mg/liter.
The proportion of patients with SCRP . 20 mg/liter was signifi-
cantly higher in group III than in the other groups. The relation-
ship between SCRP and age is shown in Figure 2, which demon-
strates that practically all patients with SCRP higher than 20
mg/liter were above 50 years of age. The relationship between SAlb
and SCRP is shown in Figure 3, demonstrating that 20 of 25
patients with SCRP higher than 20 mg/liter had serum albumin
values below 35 g/liter. In patients with elevated SCRP, were found
a negative correlation with SAlb (r 5 20.48). The various co-
morbid conditions in patients with SCRP higher than 20 mg/liter,
present at the time when the patients were examined, are given in
Table 4, which shows that the main cause of an elevated SCRP was
infectious disease.
The concentrations of free amino acids in plasma are presented
in Table 5. The mean plasma concentrations of all essential amino
acids, except lysine, phenylalanine and threonine, were lower in
one or more of the patient groups than in the controls. The levels
of the branched-chain amino acids, (isoleucine, leucine and
valine) were reduced below the control levels in group I and the
mean values gradually fall in group II and group III; a linear trend
was significant (P , 0.05) for leucine and the sum of concentra-
tions of the branched-chain amino acids (SBCAA). The sum of
concentrations of the essential amino acids was lower in groups II
and group III than in controls. Among the non-essential amino
acids, the mean plasma levels of arginine, citrulline, glutamic acid
and ornithine were increased in one or more of the patient
groups, compared to the controls.
Correlations
A correlation matrix, presenting Spearman’s rank correlation
coefficients for the HD patients, is given in Table 6. The SGNA
score was negatively correlated with the anthropometric variables
(%A/DBW, HGS, BFM and MAMC), the strongest correlations
being with %A/DBW (r 5 20.61) and MAMC (r 5 20.64). The
anthropometric variables were also mutually correlated with each
other with the strongest correlations being between %A/DBW
and MAMC (r 5 0.73), %A/DBW and BFM (r 5 0.52) and BFM
and MAMC (r 5 0.50). Serum albumin was negatively correlated
with the SGNA score (r 5 20.40) and positively correlated with
HGS (r 5 0.42), MAMC (r 5 0.24), p-IGF-1 (r 5 0.39) and serum
cholesterol (SChol; r 5 0.30) and (weakly) with nPNA (r 5 0.20),
but not with serum creatinine (SCr). Plasma IGF-1 was more
strongly correlated than SAlb with HGS (r 5 0.56) and MAMC
(r 5 0.34), that is, variables which are related to somatic muscle
protein mass with SCr (r 5 0.36), which also to some extent reflects
the size of the muscle mass, and with SBCAA (that is, those
amino acids that are mainly metabolized in muscle tissue).
SBCAA was also correlated with MAMC (r 5 0.32) and (more
weakly) with nPNA (r 5 0.21) and the SGNA score (r 5 0.23).
Blood standard bicarbonate was not significantly correlated with
any of the anthropometric or biochemical factors used to assess
protein-energy malnutrition.
Influence of age and sex
Age was negatively correlated with the SGNA score, HGS, SAlb,
p-IGF-1, SCr and nPNA (Table 6). Comparison of patients older
than 65 years (the median age) with younger patients (Table 8)
showed that a higher proportion of the elderly patients were
malnourished. The elderly patients also had signs of lower somatic
(muscle) protein stores (lower HGS and MAMC), lower SAlb and
p-IGF-1 levels and lower nPNA than the younger ones. Body fat
mass (BFM), nPNA and Kt/Vurea were higher and SCr was lower
in females than in males (Table 6).
Fig. 1. Distribution between the three patient groups for protein equiv-
alence of nitrogen appearance (PNA), normalized to desirable body wt
(DBW).
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Predictors of malnutrition as evaluated by SGNA
To analyze this, we performed logistic regression analysis,
entering all variables, which were correlated with SGNA by
univariate analysis (Table 6), with the presence of malnutrition
(belonging to groups II 1 III) or not (belonging to group I) as
outcome variable. The results, presented in Table 7, show that
%A/DBW, HGS and SAlb predicted malnutrition to about the
same extent, MAMC as a predictor did almost reach statistical
significance, whereas all the other variables were non-significant
(P . 0.2).
Influence of cardiovascular disease
Patients with cardiovascular disease (CVD) were older and
malnutrition was commoner than in patients without CVD, and
they had lower HGS, SCr, SAlb, p-IGF-1 and hemoglobin (Tables
8 and 9).
Predictors of serum albumin
Stepwise multiple regression analysis was used to find statisti-
cally significant independent predictors of SAlb in the HD patients
(Table 10). Nutritional status (SGNA) was the strongest predic-
tor, followed by s-cholesterol, protein intake as assesed by nPNA,
age, SCRP and sex. The regression model could explain 37% of the
variation in SAlb.
The 36 patients who did not participate in this study comprised
19 males, 17 females, aged 56 (26 to 79) years. Five patients (13%)
were diabetics. Absolute body weight was 65 6 14 kg, nPNA was
1.14 6 0.33 g/kg, Kt/Vurea was 1.41 6 0.28. They did not differ
significantly from the study population regarding age and sex
distribution, percent diabetics, body wt, time on dialysis, nPNA
and Kt/Vurea.
DISCUSSION
In this study, we intended to include all patients on mainte-
nance HD who were treated at Huddinge University Hospital and
its satellite units, and who had been dialyzed for more than two
weeks. However, we failed to recruit 36 patients, representing
22% of the population, who refused to participate or were not
referred by the staff. Nevertheless, we believe that the population
studied was representative of the whole population, since the
Table 2. Anthropometric data in 128 hemodialysis (HD) patients and 44 controls (mean 6 SD)
Gender Controls Group I Group II Group III
Length, cm male 180 6 8 179 6 6 174 6 7 169 6 6bc
female 164 6 8 162 6 8 163 6 8 163 6 9
Actual body weight (ABW), kg male 74 6 7 78 6 9 67 6 10a 62 6 10bc
female 62 6 11 66 6 14 54 6 9 48 6 15ac
ABW in % of desirable body weight male 99 6 3 107 6 2 95 6 12 84 6 8c
female 101 6 21 110 6 18 90 6 12 73 6 6bc
Triceps skinfold thickness, mm male 10.4 6 3.7 13.5 6 5.8 9.8 6 3.9 4.8 6 0.2ac
female 20.1 6 6.9 21.1 6 6.5 12.4 6 5.9ac 7.1 6 3.3ac
Mid-arm muscle circumference, cm male 27 6 2 28 6 2 24 6 2 21 6 2bc
female 24 6 2 25 6 3 22 6 3c 19 6 2ac
Hand grip strength, kg male 49 6 10 34 6 12a 24 6 9b 12 6 11bc
female 27 6 5 22 6 9 13 6 7b 11 6 6bc
Body fat, % of body weight male 20 6 5 26 6 5 23 6 6 10 6 2ac
female 35 6 7 36 6 7 29 6 5 24 6 5ac
Statistically significant differences between patients and controls are marked a P , 0.05; b P , 0.01, and between patient groups I and group II and
III are marked c P , 0.05
Table 3. Biochemical characteristics of 128 hemodialysis (HD) patients and 44 controls (mean 6 SD)
Dialysis-free day
Controls
N 5 44
Group I
N 5 46
Group II
N 5 65
Group III
N 5 17
Serum creatinine, mmol/liter 84 6 10 746 6 196 694 6 206 526 6 195
c
Serum urea, mmol/liter 5 6 1 18 6 5 21 6 7 19 6 4
Standard bicarbonate, mmol/liter 25 6 2 24 6 2 24 6 3 24 6 2
Serum phosphate, mmol/liter 1.0 6 0.4 1.9 6 0.4b 1.8 6 0.5b 1.8 6 0.5b
Serum cholesterol, mmol/liter 5.2 6 1.1 5.6 6 1.3 5.4 6 1.5 5.4 6 1.5
Serum triglycerides, mmol/liter 1.2 6 0.2 1.7 6 0.8 1.4 6 0.6 1.3 6 0.7
Serum total protein, g/liter 73 6 2 76 6 8 76 6 7 71 6 6
Serum albumin, g/liter 42 6 4 35 6 3b 32 6 5cd 30 6 5cd
Elevated serum CRP .20 mg/liter 17% 29% 64%d
Plasma IGF-1, ng/ml 1822389 221 6 94 160 6 104d 131 6 89d
Plasma C3, ng/ml 0.520.85 0.60 6 0.1 0.59 6 0.1 0.63 6 0.11
Serum transferrin, mmol/liter 2.123.6a 2.3 6 0.6 2.0 6 0.5 2.0 6 0.4
Blood hemoglobin, g/liter 139 6 9 102 6 2b 97 6 14b 96 6 18b
Blood lymphocytes, 109/liter 1.9 6 0.7 1.8 6 0.9 1.6 6 0.5 1.9 6 1.4
a Normal range of serum transferrin and IGF-1 of the clinical laboratories.
Statistically significant differences between patients and controls are marked b P , 0.05; c P , 0.01 and between patients group I and patient group
II and III are marked d P , 0.05
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patients who did not participate had about the same age and
gender distribution, diagnoses of renal disease and dialysis data.
The high proportion of elderly patients and those with CVD
may indirectly be a consequence of the efficient renal transplan-
tation program in operation for many years in Sweden, no less
than 55% of the total patient population on renal replacement
therapy having a functioning renal graft [28]. Since patients who
are given transplants tend to be younger and have less severe
medical complications, this will result in a higher proportion of
elderly patients and patients with CVD and other co-morbid
conditions on maintenance dialysis.
In our primary analysis of the incidence of protein-energy
malnutrition, we used SGNA, which gives an overall assessment of
the degree of malnutrition, but does not include more sophisti-
cated anthropometric measurements or biochemical parameters.
Subjective global nutritional assessment has been shown to be a
useful and reliable tool for clinical assessment of nutritional status
in post-traumatic patients [20, 21], but to our knowledge has been
applied in only a few studies of patients with renal failure [5, 7,
29]. In general, the grouping of patients according to SGNA
seems to accord with anthropometric measurements such as body
wt, fat mass, arm muscle circumference and hand-grip strength, as
well as with biochemical parameters, such as SAlb and p-IGF-1, all
of which were gradually more reduced in groups II and III
patients than in group I. Logistic regression analysis revealed that
two anthropometric variables (%A/DBW and HGS) and one
biochemical variable (SAlb) predicted malnutrition independently
and to about the same extent. Other variables which were
correlated with SGNA, such as BFM, p-IGF-1 and SCr, did not
reach significance as independent predictors, presumably because
they covariated with the most predictive ones.
Fig. 2. Relationship between age and serum C-reactive protein (SCRP).
All patients except one with serum CRP . 20 mg/liter were over 50 years
of age.
Fig. 3. Relationship between serum C-reactive protein (SCRP) and serum
albumin. Twenty-five of 28 patients with SCRP . 20 g/liter had serum
albumin (SAlb) , 35 g/liter. For SCRP values $ 10 mg/liter, there was a
significant correlation between (log) SCRP and SAlb (r 5 0.48, P , 0.0001).
Table 4. Co-morbid conditions in 28 HD patients with serum
C-reactive protein .20 mg/liter
SCRP .20 mg/liter
Infection and sepsis 17
Cardiovascular diseases 2
Gastrointestinal diseases 5
Malignant tumor 4
Table 5. Plasma free amino acid concentrations mmol/liter
(mean 6 SD) in 118 hemodialysis patients and 44 controls
Controls
N 5 44
Group I
N 5 44
Group II
N 5 58
Group III
N 5 16
Essential AA
Histidine 83 6 13 81 6 16 74 6 16 72 6 15b
Isoleucine 67 6 17 59 6 16 56 6 16b 51 6 14b
Leucine 134 6 47 103 6 26c 91 6 29c 82 6 20c
Lysine 178 6 42 194 6 49 178 6 50 188 6 58
Methionine 33 6 10 24 6 6b 20 6 5b 21 6 6b
Phenylalanine 52 6 10 67 6 18 59 6 15 62 6 16
Threonine 127 6 30 118 6 31 114 6 37 111 6 47
Tryptophan 46 6 13 27 6 9c 23 6 7c 27 6 11c
Tyrosinea 59 6 20 47 6 18b 46 6 14b 53 6 20
Valine 222 6 48 187 6 43c 171 6 53c 163 6 11c
Non-essential AA
Alanine 312 6 90 349 6 94 311 6 111 305 6 99
Arginine 84 6 20 100 6 27b 96 6 29 85 6 35
Asparagine 50 6 12 52 6 11 50 6 14 53 6 16
Citrulline 30 6 9 109 6 29c 105 6 34c 95 6 36c
Glutamic acid 33 6 15 43 6 24 47 6 25b 54 6 35c
Glutamine 638 6 89 651 6 92 641 6 108 643 6 135
Glycine 246 6 75 302 6 134 275 6 79 324 6 162
Ornithine 62 6 14 82 6 31b 77 6 21b 80 6 31
Serine 122 6 29 82 6 18c 85 6 19c 92 6 27
Taurine 50 6 14 44 6 21 40 6 16 42 6 25
Sums of amino acids
Total AA 2635 6 358 2693 6 318 2519 6 408 2615 6 542
Non essential AA 1677 6 252 1725 6 238 1632 6 285 1685 6 400
Essential AA 907 6 160 831 6 184 808 6 180c 817 6 156c
BCAA 424 6 106 351 6 78c 319 6 93c 301 6 56c
a Plasma tyrosine is considered to be essential in chronic uremic patient.
Statistically significant differences between patients and controls are
marked b P , 0.05; c P , 0.01
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Evaluated by SGNA, 64% of our patients had signs of protein-
energy malnutrition, which, however, was mild in most of them,
only 12% being classified as moderately malnourished and 2
patients (, 2%) as severely malnourished. Nevertheless, the total
incidence of malnutrition was higher than in most studies previ-
ously reported [7, 30], which raises the question whether this can
be explained by some special features in our HD population.
One factor may be the relatively high age, with no less than 50%
of the patients above the age of 65 years. It is well known that
senescence per se involves a gradual involution of body cell mass
[31, 32]. The observation that elderly patients were more fre-
quently malnourished than younger ones according to SGNA, and
had lower body wt, HGS, MAMC, SAlb and p-IGF-1 (Table 8),
accords with this view. The protein intake, estimated as nPNA,
was also significantly lower in the elderly than in the younger
patients, which confirmed earlier results showing an inverse
correlation between nPNA and age [33].
Several co-morbidity factors may also have influenced the
nutritional status either by causing a reduced nutritional intake or
by promoting catabolism [12]. Thus, diabetes mellitus was more
frequent among patients in group III than in the other two groups.
There was also a high prevalence of CVD in the whole patient
population (77%), and especially among the malnourished patient
groups and the elderly patients. Another association between
malnutrition and co-morbidity is evident from our observation
that markedly elevated SCRP (. 20 mg/liter), which in most cases
was caused by infections and almost exclusively observed in patients
above 50 years of age (Fig. 2), was more common in malnourished
patients than in patients with normal nutrtional status.
Table 6. Spearman rank correlation matrix for 14 variables
Variable SGNA score Age Sex M/F %A/DBW HGS MAMC %BFM nPNA Kt/Vurea SAlb p-IGF-1 SCr SBCAA
Age 0.27b
Sex M/F 0.15 0.07
%A/DBW 20.61c 20.15 20.20
HGS 20.46c 20.54c 0.00 0.23a
MAMC 20.64c 20.18 20.08 0.73c 0.36c
%BFM 20.37c 0.04 0.43c 0.52c 0.03 0.50c
nPNA 20.01 20.19a 0.21a 20.04 0.24b 0.07 20.00
Kt/Vurea 0.06 20.03 0.34
c 20.33c 0.03 20.12 0.10 0.37c
SAlb 20.40
c 20.32c 20.12 0.00 0.42c 0.24b 20.09 0.20a 0.13
p-IGF-1 20.36c 20.49c 0.06 0.24b 0.56c 0.34c 0.12 0.34c 0.03 0.39c
SCr 20.30
b 20.22a 20.21a 0.36c 0.15 0.31c 20.04 0.10 20.35c 0.10 0.36c
SBCCA 20.23a 20.13 20.24b 0.27b 0.08 0.32c 0.13 0.21a 0.00 0.16 0.28b 0.04
Schol 20.09 0.02 0.30
b 20.03 0.19a 0.15 0.27b 0.18 0.29c 0.30b 0.10 0.04 0.02
The anthropometric variables, hand grip strength (HGS), mid-arm muscle circumference (MAMC) and body fat mass (%BFM), were entered into
the analysis as percentage of the controls; % A/DBW, actual body weight in percent of desirable body weight, SBCAA, sum of the plasma concentrations
of the branched chain amino acids (isoleucine, leucine and valine). Abbreviations are: BFM, body fat mass; nPNA, protein equivalence of nitrogen
appearance; Kt/Vurea, dialyzer 1 renal urea clearance, dialysis time and volume obtained by urea kinetic modeling; SAlb, serum albumin; p-IGF-1,
plasma insulin-like growth factor-1; SCr, serum creatinine; SBCAA, branched chain amino acids that are metabolized mainly in muscle tissue.
a P , 0.05, b P , 0.01 and c P , 0.001
Table 7. Logistic regression analysis of anthropometric and biochemical
predictors of malnutrition according to SGNA (groups II1III viz
group I) in HD patients, omitting variables for which P . 0.1
Estimate x2
P
value
Intercept 240.42 13.64 0.0002
%HGS 0.06 6.39 0.012
%A/DBW 0.11 6.01 0.014
Serum albumin, g/liter 0.31 6.00 0.014
%MAMC 0.11 3.28 0.070
Total r2 r 5 0.56
The anthropometric variables, hand grip strength (HGS) and mid-arm
muscle circumference (MAMC) were entered into the analysis as percent-
age of the controls. Abbreviation is: %A/DBW, absolute body weight in
percent of desirable body weight.
Table 8. Statistical comparison of younger and elderly hemodialysis
patients
# 65 years . 65 P
Male/female 35/28 41/24
Plasma IGF-1, ng/ml 219 6 94 138 6 97 0.0001
a
Serum albumin, g/liter 34.5 6 4.9 31.7 6 3.9 0.0002a
% HGS 70.2 6 24.5 45.2 6 23.0 0.001a
% MAMC 97.8 6 10.7 92.6 6 11.7 0.01a
Percent malnourished (SGNA) 46% 68% 0.013b
nPNA 1.16 6 0.24 1.06 6 0.21 0.017a
Kt/Vurea 1.37 6 0.26 1.37 6 0.27 0.95
a
Abbreviations are in the Appendix.
a Statistical significance was tested with Student’s t-test
b Statistical significance was tested with Chi-squared test
Table 9. Statistical comparison of hemodialysis patients with and
without cardiovascular diseases (CVD)
No CVD CVD P
Male/female 34/17 42/35
Percent malnourished (SGNA) 33% 73% 0.0001
a
Age, years 56 6 16 64 6 12 0.0025b
Serum creatinine, mmol/liter 756 6 211 648 6 201 0.007b
Serum albumin, g/liter 34.4 6 4.8 32.3 6 4.4 0.01b
Blood hemoglobin, gpliter21 103 6 15 96 6 15 0.01b
%HGS 64.2 6 29.1 52.5 6 23.9 0.02b
Plasma IGF-1, ng/ml 200 6 111 162 6 97 0.05c
Serum C-reactive protein,
mg/liter .20
15.7% 25.9% 0.16a
nPNA 1.12 6 0.23 1.11 6 0.22 0.97b
Kt/Vurea 1.39 6 0.27 1.35 6 0.26 0.38
b
a Statistical significance was tested with Chi-squared test
b Statistical significance was tested with Student’s t-test
c Statistical significance was tested with non parametric Mann-Whitney
test
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It has recently been reported that hypoalbuminemia is associ-
ated with presence of and de novo development of cardiac disease
in HD and CAPD patients [34]. It is possible that the relationship
is inverse, that is, that cardiac disease leads to malnutrition and
hypoalbuminemia. Several studies show that patients having
chronic cardiac failure without renal disease may develop weight
loss and other signs of malnutrition, a condition called cardiac
cachexia [35]. Cardiac failure patients have increased resting
metabolic rate [36] and fat malabsorption [37]. There is evidence
that tumor necrosis factor and other cytokines are major patho-
genetic factors in the development of cardiac cachexia [38]. These
factors may also elicit an acute phase response, resulting in,
among others, reduced synthesis of SAlb [39].
The patients in this study had mean Kt/Vurea values in the range
of 1.34 to 1.37 with no difference between the three groups that is,
the average dose of dialysis was at a level considered to be
adequate at the time when this study was performed [40]. We
found a significant correlation between Kt/Vurea and nPNA,
confirming earlier observations by several groups [33, 41, 42].
Such a correlation has been interpreted to mean that the intake of
protein depends on the dose of dialysis, presumably because
underdialyzed patients suffer from anorexia due to the influence
of uremic toxicity. However, there is also support for the view that
the correlation between Kt/Vurea and nPNA mainly reflects a
mathematical coupling because the calculations of respective
equations have components in common [42].
The mean nPNA was relatively high (1.1 to 1.2 g/kg), with no
difference between the groups, suggesting that the protein intake
was adequate. However, it has been argued that referring PNA to
actual body wt or to “normalized” body wt (nPNA) may be grossly
misleading since, by so doing, malnourished patients with a
reduced body cell mass may appear to have an adequate or high
protein intake although the intake is low in relation to the
requirements [43]. It was therefore recommended that PNA
should be referred to the desirable body wt (DBW), or ideal body
wt, which may better reflect the protein intake in relation to the
needs. When PNA was referred to DBW in the present study,
some of the malnourished patients had values far below those with
normal nutritional status (Fig. 1), being as low as 0.4 g/kg in some
of them thus suggesting that low protein intake may, indeed, have
been of important for the development of malnutrition. Kt/Vurea,
normalized to DBW, was also lower in the malnourished groups
than in patients with normal nutritional status. Considering that
the nature of uremic toxicity is still enigmatic, urea serving at best
as a “surrogate” uremic toxin, it is questionable whether genera-
tion and removal of urea really reflects the behavior of clinically
more important uremic toxins. Lacking such information, we
cannot rule out that low Kt/Vurea, normalized to DBW, may
reflect underdialysis, which leads to suppression of food intake.
Among the biochemical parameters, SAlb is most frequently
used to assess protein malnutrition, based on the concept that the
level of SAlb reflects the visceral protein status. However, this is
only partly true since there are many other factors which influence
the generation, distribution and catabolism of albumin, such as
albumin synthesis inhibition, albumin degradation, albumin losses
from the body, dilution by fluid overload and exchange between
intravascular and extravascular compartments [44]. Serum albu-
min also decreases with age in apparently healthy subjects [27].
We observed a reduction in SAlb in all three groups of patients,
which decreased in proportion to the degree of malnutrition. In
the stepwise regression analysis, the strongest independent pre-
dictor of the SAlb level was the nutritional status as evaluated by
the SGNA. Serum albumin was also correlated with nPNA (an
indicator of protein intake) and SChol (an indicator of energy
intake), suggesting that adequate nutritional intakes of protein
and energy are essential for maintaining the visceral protein
stores. Serum CRP was also a significant independent predictor of
SAlb. This accords with earlier observations in HD patients that
albumin generation is reduced during the acute phase response
and that SAlb is inversely correlated with serum concentrations of
CRP and a2-macroglobulin [39]. The conclusion that non-nutri-
tional factors influence SAlb in HD patients is supported by our
observation that SAlb was significantly decreased in patients
classified as having a normal nutritional status, compared to
age-matched controls. An independent factor that influences SAlb
in HD patients is albumin leakage through the dialysis mem-
branes, which has been observed with polysulfone dialyzers, after
repeated reuses using bleach as the disinfectant [45]. In our
study this was not a factor of importance, since none of the
dialyzers was reused. Liver disease may also reduce albumin
synthesis, but it was probably not important in this study, since
only two patients had increased serum aspartate aminotrans-
ferase levels.
Plasma IGF-1 has been introduced as an indicator of nutritional
status in renal failure patients. This correlates significantly with
other biochemical and anthropometric markers of malnutrition
and has been thought to be a better marker of malnutrition than
other serum proteins [46, 47]. In the present study, p-IGF-1 was
within normal range in the group I patients but gradually de-
creased in the group II and group III patients, suggesting that
p-IGF-1 levels distinguished between normal and malnourished
patients and reflected the degree of malnutrition. We should note
that MAMC and HGS were more strongly correlated with p-
IGF-1 than with SAlb. The results suggest that p-IGF-1 may
provide additional information as a nutritional marker, by reflect-
ing the somatic (muscle) protein stores more closely than SAlb.
In several earlier studies of nutritional status in HD patients
low serum transferrin has been shown to be a useful marker of
malnutrition. However, in the present study serum transferrin
concentrations failed to distinguish between patients with normal
nutritional status and the malnourished patient groups. The
reason for this is presumably that a large proportion of the
patients were treated with rhEPO and i.v. or oral iron, which may
independently modify serum transferrin [48, 49].
We observed low concentrations of all essential amino acids,
Table 10. Forward stepwise multivariate regression analysis of
predictors of serum albumin in hemodialysis patients
Estimate
Standard
error
P
value
Intercept 32.54 0.41 ,0.0001
SGNA normal and malnourished 1.46 0.35 ,0.0001
Serum cholesterol .5 and #5 mmol/liter 1.42 0.37 0.0007
nPNA groups ,1.1 and $1.1 g/kg 0.96 0.34 0.005
Age groups ,65 years and $65 years 0.94 0.36 0.009
CRP groups ,20 and $20 mg/liter 0.99 0.41 0.016
Sex, female and male 0.81 0.37 0.029
All variables that were significantly correlated with serum albumin
(Table 6) were included into the initial model. Total r2 adjusted to r 5
0.37. Abbreviations are in the Appendix.
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except lysine and phenylalanine, in one or more of the patient
groups. However, there was a trend towards decreasing values
only for the BCAA, the degree of malnutrition being significant
for leucine and the sum of concentration of BCAA. An earlier
study [1] reported that valine appears to be the amino acid in
plasma which best predicted the nutritional status; our results
suggest that leucine may be at least as good a predictor as valine.
However, the relatively small differences in mean values and the
large overlap between the groups argue against these amino acids
as sensitive indicators of the nutritional status. It should also be
emphasized that for each free amino acid the plasma pool
represents only a small fraction of the total body content. For
most amino acids the intracellular concentration in skeletal
muscle (the largest pool of free amino acids immediately available
for protein synthesis) is higher than in plasma [50]. Several studies
showed that in patients with renal failure the plasma concentra-
tions of several amino acids do not reflect the intracellular
concentrations in the muscle cells [51]. Therefore, one may
question whether it is worthwhile to use plasma amino acid
determinations for assessment of malnutrition, especially since
the methods are expensive and time consuming.
Among factors causing protein catabolism and malnutrition in
renal failure patients, metabolic acidosis has attracted much
interest in recent years. It has become increasingly evident that
metabolic acidosis, rather than uremia per se, may be an important
stimulus for net protein catabolism by stimulating BCAA catab-
olism and proteolysis in skeletal muscle [52–55].
Earlier studies have shown no apparent association between
total CO2 or plasma bicarbonate levels and nutritional status as
assessed by SAlb [56, 57]. Only one study of CAPD patients
reported that the increases in body wt and mid-arm circumference
were greater in a group with fully corrected acidosis than in group
with lower plasma bicarbonate levels [58]. In the present study, we
observed no significant correlation between standard blood bicar-
bonate and any of the nutritional variables recorded. However, it
should be emphasized that the acid-base balance was well con-
trolled in most of the patients, only 16% having a predialysis
standard bicarbonate # 21 mmol/liter. Therefore, it cannot be
excluded that a higher degree of acidosis may have a harmful
effect on nutritional status by enhancing muscle proteolysis.
Nevertheless, our observations of no association between blood
bicarbonate and any of the anthropometric and biochemical
variables recorded strongly suggest that metabolic acidosis was
not an important factor for the development of protein malnutri-
tion in our patients.
In summary, a high proportion of HD patients in this study
showed signs of malnutrition, which was mild in the majority of
patients. Clinical factors associated with malnutrition were high
age, presence of cardiovascular disease and diabetes mellitus. The
SAlb level was influenced not only by nutritional status and protein
intake but also independently by age, SCRP and sex. Plasma IGF-1
levels also reflected the presence and severity of malnutrition and
appeared to be more closely associated than SAlb with indices of
somatic protein mass. Elevated SCRP, which mainly reflected the
presence of infection/inflammation, was more common in elderly
than in younger patients. Plasma amino acid levels, with the
possible exception of the BCAA, seem to be poor predictors of
malnutrition.
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APPENDIX
Abbreviations used in this article are: ABW, absolute body weight;
ANOVA, analysis of variance; SBCAA, sum of concentrations of
branched-chain amino acids; BFM, body fat mass; CVD, cardiovascular
disease; DBW, desirable body weight; HD, hemodialysis; HGS, hand-grip
strength; IGF-1, insulin-like growth factor-1; Kt/Vurea, dialyzer 1 renal
urea clearance, dialysis time and volume obtained by urea kinetic model-
ling; MAC, mid-arm circumference; MAMC, mid-arm muscle circumfer-
ence; nBW, normalized body weight; nPNA, protein equivalence of
nitrogen appearance; p-IGF-I, plasma insulin-like growth factor-1; SAlb,
serum albumin; SCRP, serum C-reactive protein; SCr, serum creatinine
SGNA, subjective global nutritional assessment; TSF, triceps skinfold
thickness.
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